Huge Underuse of Germline Testing for Cancer Patients

Rates of germline genetic testing for patients newly diagnosed with common cancers are far below recommended levels, prompting calls for innovative solutions.
Medscape Medical News

source https://www.medscape.com/viewarticle/992869?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?